Literature DB >> 19627258

Antibiotic prophylaxis for children at risk of developing urinary tract infection: a systematic review.

Rintaro Mori1, Anita Fitzgerald, Craig Williams, Kjell Tullus, Kate Verrier-Jones, Monica Lakhanpaul.   

Abstract

BACKGROUND: Antibiotic prophylaxis in children who have had urinary tract infection (UTI) to prevent further infection is a common practice. The aim of this study is to reduce the development of further renal scarring by the prevention of recurrent acute pyelonephritis.
METHODS: A systematic review of randomized controlled trials assessing effectiveness of antibiotic prophylaxis in children who have recovered from a symptomatic UTI and children in whom vesico-ureteric reflux has been identified independent of a history of acute UTI was carried out by systematic search in Medline, EMBASE, the Cochrane Library and CINAHL using keywords and thesaurus terms. Identified trials were independently appraised by two researchers. Data were extracted and synthesized in meta-analyses.
RESULTS: A total of 677 children in eight trials were included in the analyses. There was no evidence of difference on meta-analysis of all the included studies, or any of the four subgroups, between the intervention and control groups in recurrence of symptomatic UTI [four trials, RR 0.96 (95% CI: 0.69-1.32]) and incidence of new or progressive renal scarring [four trials, overall RR 1.15 (95% CI: 0.75-1.78)].
CONCLUSION: Given the lack of evidence on positive benefit of using prophylactic antibiotics for children at risk of developing UTI, routine use of antibiotics for these children is not recommended.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19627258     DOI: 10.1111/j.1651-2227.2009.01433.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Antibiotic prophylaxis in vesicoureteral reflux: A practice revisited.

Authors:  Jessica Robinson
Journal:  Can Pharm J (Ott)       Date:  2013-03

Review 2.  Antibiotic prophylaxis in pediatric urology: an update.

Authors:  Saul P Greenfield
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

Review 3.  The impact of vesicoureteral reflux treatment on the incidence of urinary tract infection.

Authors:  George M Wadie; Kevin P Moriarty
Journal:  Pediatr Nephrol       Date:  2011-03-06       Impact factor: 3.714

4.  Costs and consequences of universal sibling screening for vesicoureteral reflux: decision analysis.

Authors:  Jonathan C Routh; Frederick D Grant; Paul Kokorowski; Richard S Lee; Frederic H Fahey; S Ted Treves; Caleb P Nelson
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

Review 5.  A guideline for the inpatient care of children with pyelonephritis.

Authors:  Aftab S Chishti; Erich C Maul; Rubén J Nazario; Jeffrey S Bennett; Stefan G Kiessling
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

6.  Long-term antibiotics for preventing recurrent urinary tract infection in children.

Authors:  Gabrielle Williams; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2019-04-01

Review 7.  Current status of long-term antibiotic prophylaxis for urinary tract infections in children: An antibiotic stewardship challenge.

Authors:  Sarah S Alsubaie; Mazin A Barry
Journal:  Kidney Res Clin Pract       Date:  2019-12-31

8.  Culture-positive urinary tract infection following micturating cystourethrogram in children.

Authors:  Simeon Ngweso; Munyaradzi Nyandoro; Tatenda Nzenza; Ting Yi Cheow; Fiona Bettenay; Andrew Barker; Japinder Khosa; Naeem Samnakay
Journal:  Asian J Urol       Date:  2021-08-26

9.  Revised guidelines on management of antenatal hydronephrosis.

Authors:  A Sinha; A Bagga; A Krishna; M Bajpai; M Srinivas; R Uppal; I Agarwal
Journal:  Indian J Nephrol       Date:  2013-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.